U. Schubert

654 total citations
14 papers, 478 citations indexed

About

U. Schubert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, U. Schubert has authored 14 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in U. Schubert's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). U. Schubert is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). U. Schubert collaborates with scholars based in Germany, France and Belgium. U. Schubert's co-authors include Hartmut Hecker, Leonard B. Saltz, Patrick Schöffski, Gunnar Folprecht, C.-H. Köhne, Claus‐Henning Köhne, Eric Van Cutsem, Richard Stephens, Philippe Rougier and Jean‐Yves Douillard and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

U. Schubert

13 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Schubert Germany 9 338 114 99 96 93 14 478
Sojiro Morita Japan 16 296 0.9× 274 2.4× 135 1.4× 39 0.4× 390 4.2× 67 656
Émilie Uldry Switzerland 15 114 0.3× 107 0.9× 188 1.9× 88 0.9× 269 2.9× 54 600
Qiang He China 14 161 0.5× 94 0.8× 85 0.9× 32 0.3× 105 1.1× 57 505
Nansheng Cheng China 15 191 0.6× 251 2.2× 136 1.4× 37 0.4× 333 3.6× 38 630
Horng‐Yuan Wang Taiwan 17 179 0.5× 266 2.3× 121 1.2× 27 0.3× 397 4.3× 87 754
Songjiang Huang China 13 89 0.3× 63 0.6× 315 3.2× 53 0.6× 143 1.5× 42 604
Xuefeng Shan China 12 67 0.2× 100 0.9× 72 0.7× 24 0.3× 70 0.8× 24 442
Andrea Corkhill United Kingdom 8 317 0.9× 115 1.0× 28 0.3× 93 1.0× 83 0.9× 12 481
Haleh Vaziri United States 9 153 0.5× 110 1.0× 58 0.6× 72 0.8× 210 2.3× 43 449
Yoshikazu Toyoki Japan 18 238 0.7× 125 1.1× 331 3.3× 35 0.4× 565 6.1× 83 787

Countries citing papers authored by U. Schubert

Since Specialization
Citations

This map shows the geographic impact of U. Schubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Schubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Schubert more than expected).

Fields of papers citing papers by U. Schubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Schubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Schubert. The network helps show where U. Schubert may publish in the future.

Co-authorship network of co-authors of U. Schubert

This figure shows the co-authorship network connecting the top 25 collaborators of U. Schubert. A scholar is included among the top collaborators of U. Schubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Schubert. U. Schubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Metzler, Berthold, et al.. (2008). Toxische Diphtherie durch Corynebacterium ulcerans. DMW - Deutsche Medizinische Wochenschrift. 119(15). 548–552. 2 indexed citations
2.
Folprecht, Gunnar, Michel Seymour, Leonard B. Saltz, et al.. (2008). Irinotecan/Fluorouracil Combination in First-Line Therapy of Older and Younger Patients With Metastatic Colorectal Cancer: Combined Analysis of 2,691 Patients in Randomized Controlled Trials. Journal of Clinical Oncology. 26(9). 1443–1451. 161 indexed citations
3.
Carrato, Alfredo, C.-H. Köhne, Laurent Bedenne, et al.. (2006). Folinic acid modulated bolus 5-FU or infusional 5-FU for adjuvant treatment of patients of UICC stage III colon cancer: Preliminary analysis of the PETACC-2-study. Journal of Clinical Oncology. 24(18_suppl). 3563–3563. 13 indexed citations
4.
Folprecht, Gunnar, P. Rougier, Leonard B. Saltz, et al.. (2006). Irinotecan in first line therapy of elderly and non-elderly patients with metastatic colorectal cancer: Meta-analysis of four trials investigating 5-FU and irinotecan. Journal of Clinical Oncology. 24(18_suppl). 3578–3578. 16 indexed citations
5.
Sayk, Friedhelm, Inge Bos, U. Schubert, Thilo Wedel, & Hans-H. Sievers. (2005). Histopathologic Findings in a Novel Decellularized Pulmonary Homograft: An Autopsy Study. The Annals of Thoracic Surgery. 79(5). 1755–1758. 39 indexed citations
6.
Hegewisch-Becker, S., Martina Sterneck, U. Schubert, et al.. (2004). Phase I/II trial of bortezomib in patients with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 22(14_suppl). 4089–4089. 13 indexed citations
7.
Hegewisch-Becker, S., Martina Sterneck, U. Schubert, et al.. (2004). Phase I/II trial of bortezomib in patients with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 22(14_suppl). 4089–4089. 25 indexed citations
8.
Schöffski, Patrick, Mathias Freund, Dennis R. Petersen, et al.. (1998). Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study. BMJ. 317(7155). 379–384. 56 indexed citations
9.
Köhne, C.-H., Patrick Schöffski, H. Wilke, et al.. (1998). Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.. Journal of Clinical Oncology. 16(2). 418–426. 116 indexed citations
10.
Gábor, M, et al.. (1996). Which antibiotic is better for the treatment of infections of the lower respiratory tract?. International Journal of Antimicrobial Agents. 6. S73–S77. 5 indexed citations
11.
12.
Köhne, C.-H., H. Wilke, Hartmut Hecker, et al.. (1995). Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. Annals of Oncology. 6(5). 461–466. 24 indexed citations
13.
Schöffski, Patrick, C.-H. Köhne, Ute Schellenberger, et al.. (1995). 284 Does effective chemotherapy for metastatic colorectal cancer (CC) improve quality of life (QL)? Preliminary results of a randomized phase II-study using the eortc QLQ C30. European Journal of Cancer. 31. S62–S62. 4 indexed citations
14.
Schubert, U., et al.. (1979). [The prosthesis hygiene index--a method for documentation and health education].. PubMed. 29(1). 29–31. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sojiro Morita Breakdown of academic impact, for papers by Émilie Uldry Breakdown of academic impact, for papers by Qiang He Breakdown of academic impact, for papers by Nansheng Cheng Breakdown of academic impact, for papers by Horng‐Yuan Wang Breakdown of academic impact, for papers by Songjiang Huang Breakdown of academic impact, for papers by Xuefeng Shan Breakdown of academic impact, for papers by Andrea Corkhill Breakdown of academic impact, for papers by Haleh Vaziri Breakdown of academic impact, for papers by Yoshikazu Toyoki
Rankless by CCL
2026